Similarly, Lactobacillus fermentum CQPC06 improves microbial composition in NAFLD mice, enhances lipid oxidation (via PPARα, cholesterol 7 alpha-hydroxylase (CYP7A1), carnitine palmitoyltransferase 1 (CPT1), and lipoprotein lipase (LPL)), and downregulates adipogenic pathways (PPARγ, C/EBPα) (Mu et al., 2020). This evidence concerns the gene LPL and metabolic dysfunction-associated steatotic liver disease.